|
|
Home
> CSL Behring - USA Homepage
CSL Behring is committed to saving lives and improving the quality of life for people with rare and serious diseases worldwide. Our life-saving biotherapies are used in the treatment of hemophilia, von Willebrand disease, immune deficiencies and genetic emphysema.
04 May 20124-Factor PCC Safety Profile Consistent With US Standard of Care
04 May 2012Study Shows 4-Factor PCC As Effective As US Standard of Care
20 April 2012CSL Behring Executive Named 2012 Risk Manager of the Year
18 April 2012Feature Story: Journey to a VWD Diagnosis
18 April 2012HealthyWomen Asks: Do You Know the Signs of VWD?
26 March 2012Public Policy Update
|